首页> 外国专利> Photosensitizer for photodynamic diagnosis or therapy and photodynamic therapy using the same

Photosensitizer for photodynamic diagnosis or therapy and photodynamic therapy using the same

机译:用于光动力诊断或治疗的光敏剂以及使用该光敏剂的光动力疗法

摘要

The present invention relates to a photosensitizer for photodynamic diagnosis or treatment and a photodynamic therapy method using the same. The present inventors have found that the conventional photosensitizers are not decomposed in the body and thus they are difficult to be removed from the living body and thus cause nonspecific cytotoxicity. On the other hand, the photosensitizer for photodynamic therapy, hyaluronic acid and fullerene, The conjugated hyaluronic acid-fullerene conjugate and the hyaluronic acid-fullerene conjugate conjugated with a detectable compound that can be inserted into the DNA fragment are biodegradable and can be easily removed from the living body. In addition, by improving water solubility by adding water to fullerene, it exhibits cell killing ability through generation of oxygen with high optical properties, and increases particle stability in blood, thereby increasing drug efficiency and maximizing therapeutic effect. In addition, the photodynamic therapy method of the present invention can be applied to a first photodynamic therapy using a hyaluronic acid-fullerene conjugate, and a hyaluronic acid-fullerene conjugate conjugated with a detectable compound that can be inserted into a DNA fragment, , Or when a second photodynamic therapy is applied to the central necrosis of the tumor, cancer cells can be killed more effectively than the photodynamic therapy using only the hyaluronic acid-fullerene conjugate, and the therapeutic period can be shortened .
机译:本发明涉及用于光动力诊断或治疗的光敏剂以及使用该光敏剂的光动力治疗方法。本发明人发现,常规的光敏剂在体内不分解,因此难以从活体中除去,从而引起非特异性细胞毒性。另一方面,用于光动力疗法的光敏剂,透明质酸和富勒烯,与可插入到DNA片段中的可检测化合物结合的共轭透明质酸-富勒烯共轭物和透明质酸-富勒烯共轭物是可生物降解的并且易于去除。来自活体。另外,通过向富勒烯中添加水来改善水溶性,其通过产生具有高光学性质的氧来表现出细胞杀伤能力,并且增加了血液中的颗粒稳定性,从而提高了药物效率并最大化了治疗效果。另外,本发明的光动力疗法方法可以应用于使用透明质酸-富勒烯缀合物和与可插入到DNA片段中的可检测化合物缀合的透明质酸-富勒烯缀合物的第一光动力疗法。当将第二种光动力疗法应用于肿瘤的中心坏死时,与仅使用透明质酸-富勒烯缀合物的光动力疗法相比,可以更有效地杀死癌细胞,并且可以缩短治疗周期。

著录项

  • 公开/公告号KR101725613B1

    专利类型

  • 公开/公告日2017-04-26

    原文格式PDF

  • 申请/专利权人 가톨릭대학교 산학협력단;

    申请/专利号KR20150008224

  • 发明设计人 이은성;김솔;

    申请日2015-01-16

  • 分类号A61K47/48;A61K31/40;A61K31/728;

  • 国家 KR

  • 入库时间 2022-08-21 13:25:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号